How Romania ensures the necessary doses of COVID vaccine. How many vaccines has the European Commission negotiated with each company?



[ad_1]

Romania has secured more than 10 million doses of vaccine under the contract signed by the European Commission with Pfizer-BioNTtech, as shown in a statement from the National Information Platform on vaccination against COVID-19, RoVaccinare. These are enough to vaccinate 5 million people, but the authorities specify that they will be able to vaccinate at least 10.7 million Romanians based on the contracts for the vaccines of the other companies, which are being authorized.

Romania can access more than 10 million doses of vaccine according to the contract signed by the European Commission with Pfizer-BioNTtech, according to the RoVaccinare platform. The doses are enough to vaccinate 5 million people.

In addition, according to the statement, the European Commission aims to develop a diverse portfolio of candidate vaccines on different platforms, in order to increase the possibilities of having more vaccines available, following the marketing authorization granted by the European Medicines Agency (EMA) . .

In early January, the EMA will complete the evaluation of the second COVID-19 vaccine, developed by Moderna. The number of doses distributed to Romania of vaccines that could obtain the recommendation of the EMA and the authorization of the European Commission will be established in the same way as the contract with the first producer whose product has already passed these stages, according to the statement.

So far, the European Commission has signed contracts with six manufacturing companies. Based on these signed contracts and depending on which vaccines the EMA will continue to recommend and authorized by the European Commission, Romania will be able to access the number of doses needed to vaccinate 10.7 million people, with the possibility of.

Below is a table with the number of doses negotiated by the European Commission with each of the leading companies in the development of vaccines against the new coronavirus.

EU vaccines
Contracts negotiated by the EC with large companies that develop COVID vaccines. Photo source: ec.europa.eu

Editing: Bogdan Pacurar

[ad_2]